跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Malatan Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Malatan Plus
Approved
STANDARD
Malatan Plus
Genepharm S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3518da0b5fd810ae
Company
Genepharm S.A.
Type
Standard
Approval Details
Approval Id
3518da0b5fd810ae
Drug Approval Philippines Name
Malatan Plus
Product Name
Malatan Plus
Registration Number
DR-XY48433
Brand Name
Malatan Plus
Generic Name
Irbesartan + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg/12,5 mg
Manufacturer
Genepharm S.A.
Importer
S.M.H.P. Marketing & Consultancy
Distributor
S.M.H.P. Marketing & Consultancy
Issuance Date
30 January 2023
Expiry Date
27 October 2027
Pharmacologic Category
Angiotensin II Receptor Blocker-Diuretic Combination
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3518da0b5fd810ae
Type
Standard
Back to Philippines FDA Approvals